SS

Sahil Sapra

Active Director Director DIN 06734038
DIN 06734038 First appointment Dec 2013 Primary industry Consumer Electronics & Durables
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Dec 2013
Shareholding value •••• Premium profile

About Sahil Sapra

Data last updated:

Sahil Sapra is a Director at Chempharm Industries India Private Limited (since 2013), Director at Chempharm Clean Room System Private Limited (since 2019) and Director at Noval Remedies Private Limited (since 2020), and holds 3 more current directorships. The companies operate in Consumer Electronics & Durables, Electrnoics and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹29.19 Cr; the largest is Chempharm Industries India Private Limited at ₹28.32 Cr (FY 2025). Earlier, Sahil Sapra was an Additional Director at A R B R Exim Private Limited (2019).

DIN 06734038
Primary Designation Director
Industry Consumer Electronics & Durables
First Appointment 17 Dec 2013
Oldest Company Age 31 yrs
Largest company Chempharm Industries India Private Limited · ₹28.32 Cr (FY 2025)
Combined revenue ₹29.19 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20131995₹28.32 Cr (FY 2025)Active
Director25 Oct 20192019₹87.8 Lakh (FY 2020)Active
Noval Remedies Private Limited U24290DL2020PTC364661
Director10 Jun 20202020Active
Porte Automations Private Limited U29309UP2019PTC124733
Additional Director01 May 20202019Active
A R B R Exim Llp AAR-1926
Designated Partner02 Dec 20192019Active
Eurovita Systems Private Limited U52609DL2016PTC303043
Additional Director08 Feb 20192016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
A R B R Exim Private Limited U51500DL2006PTC155685
Additional Director08 Feb 20192006₹3 Lakh (FY 2019)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chempharm Industries India Private Limited
Noval Remedies Private Limited
Chempharm Clean Room System Private Limited
Porte Automations Private Limited
Premium access

Shareholding and investment profile for Sahil Sapra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahil Sapra

Sahil Sapra currently holds 6 directorships: Chempharm Industries India Private Limited (Director, since 17 Dec 2013, revenue ₹28.32 Cr (FY 2025)); Chempharm Clean Room System Private Limited (Director, since 25 Oct 2019, revenue ₹87.8 Lakh (FY 2020)); Noval Remedies Private Limited (Director, since 10 Jun 2020); Porte Automations Private Limited (Additional Director, since 01 May 2020); A R B R Exim Llp (Designated Partner, since 02 Dec 2019); and 1 more.

Sahil Sapra was first appointed on 17 Dec 2013 as Director at Chempharm Industries India Private Limited. The most recent appointment on record is 10 Jun 2020 at Noval Remedies Private Limited.

The 2 current companies of Sahil Sapra that report revenue have a combined latest revenue of ₹29.19 Cr: Chempharm Industries India Private Limited ₹28.32 Cr (FY 2025); Chempharm Clean Room System Private Limited ₹87.8 Lakh (FY 2020).

Sahil Sapra held 1 earlier board appointment: A R B R Exim Private Limited (Additional Director, 08 Feb 2019 to 01 Dec 2019).

The current boards of Sahil Sapra's companies include Anil Sapra (Chempharm Industries India Private Limited), Uditi Chadha (Chempharm Industries India Private Limited), Siddhartha Dutta (Chempharm Clean Room System Private Limited), Divya Kumar Jain (Noval Remedies Private Limited), Seema Moolri (Noval Remedies Private Limited), Sunil Kapoor (Noval Remedies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available